Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech
company that leverages advancements in science and technology to
build breakthrough ventures that transform human wellness, is
pleased to provide a sneak peek into its upcoming immune support
product,
Protect. Introduced by its U.S.
biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra"),
Protect continues Lifeist's commitment to offering
natural, science-backed solutions to its valued customers. An
exclusive preview of this innovative product is available for early
subscribers who sign up for bundle promotions at
https://bit.ly/mikra-december.
Protect comes in a
tasty gummy format that combines the antioxidant power of Aronia
berries1 with the reliable immune support functions of supplemental
zinc and vitamin C2, complemented by vitamin D to tackle the
shorter days in winter.A comprehensive U.S. clinical review
underscored the benefits of Aronia berries as follows:
As documented in
previous studies, Aronia berries show potent inhibitory activity
toward various types of infections, which have been attributed to
their potent antioxidant components.1
Furthermore, a Swiss clinical review concluded the
following:
These trials document
that adequate intakes of vitamin C and zinc ameliorate symptoms and
shorten the duration of respiratory tract infections including the
common cold.2
“PROTECT is another example of
our commitment to bringing science-backed natural solutions to
market, marrying the antioxidant power of Aronia berries with the
nutritional immune support of key vitamins, in the convenience of a
gummy,” said Meni Morim, CEO of Lifeist. “As we head into cold and
flu season, PROTECT can provide a defensive boost
to immunity -- and unlike pills and powders, can be taken on the go
without water. We invite new and loyal customers to sign up at
https://bit.ly/mikra-december to receive an invitation for a free
trial pack of Protect with their discounted promotional
bundle.”
Mikra is pushing biosciences beyond the expected
with the belief that it is possible to add more active, vigorous,
enjoyable, and valuable years to your life through protecting and
maintaining your cellular health. Its recent addition of two
innovative natural products aligns with Mikra's commitment to
reaching a wider audience and making their innovative products
readily available to enhance wellness journeys.
Lifeist is committed to bringing natural
products -- backed by real science -- to current and future
customers and looks forward to introducing additional new products
in the first half of 2024.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic
wellness revolution, Lifeist leverages advancements in science and
technology to build breakthrough companies that transform human
wellness. Portfolio business units include: CannMart, which
operates a B2B wholesale distribution business facilitating
recreational cannabis sales to Canadian provincial government
control boards including for CannMart Labs, a BHO extraction
facility producing high margin cannabis 2.0 products; Australian
Vapes, one of Australia’s largest online retailers of vaporizers
and accessories; and Mikra, a biosciences and consumer wellness
company developing and selling innovative therapies for cellular
health.
Information on Lifeist and its businesses can be
accessed through the links below: www.lifeist.com
https://cannmart.com https://wearemikra.com/
www.australianvaporizers.com.au
Contact: Meni MorimCEOLifeist
Wellness Inc.Ph: 647-362-0390 Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press release.
Forward-Looking Information
This news release contains “forward-looking
information” within the meaning of applicable securities laws. All
statements contained herein that are not historical in nature
contain forward-looking information. Forward-looking information
can be identified by words or phrases such as “may”, “expect”,
“likely”, “should”, “would”, “plan”, “anticipate”, “intend”,
“potential”, “proposed”, “estimate”, “believe” or the negative of
these terms, or other similar words, expressions and grammatical
variations thereof, or statements that certain events or conditions
“may” or “will” happen.
The forward-looking information contained
herein, including, without limitation, statements related to the
anticipated formulation of Mikra’s new mental health product and
expectations relating to Mikra’s future introduction of new
products, are made as of the date of this news release and are
based on assumptions management believed to be reasonable at the
time such statements were made, including without limitation,
expectations that the development of Mikra’s new immune support
product is successfully completed as anticipated, its expectation
that the nutraceutical market will develop as currently
anticipated, the nutraceutical market will continue to be a
multi-billion dollar high-margin market, the introduction of new
products and brands will generate additional revenue, expectations
that CELLF, RESCUE and other new cellular health products to be
developed by Mikra will gain market acceptance along with the
expansion of the market for nutraceutical products, as well as
other considerations that are believed to be appropriate in the
circumstances. While we consider these assumptions to be reasonable
based on information currently available to management, there is no
assurance that such expectations will prove to be correct. By its
nature, forward-looking information is subject to inherent risks
and uncertainties that may be general or specific and which give
rise to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct, and that objectives, strategic
goals and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this news release. Such factors
include, without limitation: the failure to successfully develop
Mikra’s new mental health product as anticipated and in a timely
manner, the inability of the Company to develop Mikra’s business as
anticipated, unanticipated changes to current regulations that
would adversely impact Mikra’s business, unforeseen developments
that would delay Mikra’s ability to sell newly developed
nutraceutical products, the risk that the expected demand for
nutraceutical products in general and those of Mikra in particular
does not develop as anticipated and risks relating to the Company’s
ability to execute its business strategy and the benefits
realizable therefrom. Additional risk factors can also be found in
the Company’s current MD&A filed under the Company’s SEDAR
profile at www.sedar.com. Readers are cautioned not to put undue
reliance on forward-looking information. The Company undertakes no
obligation to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise,
except as required by applicable law. Forward-looking statements
contained in this news release are expressly qualified by this
cautionary statement.
Source: Lifeist Wellness Inc.
____________________________
1 Potential Benefits of Aronia Melanocarpa Fruits and Their
Constituents in Improving Human Health -
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696386/
2 Immune-enhancing role of vitamin C and zinc and effect on
clinical conditions - https://pubmed.ncbi.nlm.nih.gov/16373990/
Grafico Azioni Lifeist Wellness (TSXV:LFST)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Lifeist Wellness (TSXV:LFST)
Storico
Da Mag 2023 a Mag 2024